WHO ICTRP trial
A substudy of the PLAPCI trial comparing Phospholipase A2 release with tissue…
ACTRN12611000869976 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12611000869976 |
|---|---|
| Public title | A substudy of the PLAPCI trial comparing Phospholipase A2 release with tissue characteristics as determined by invasive ultrasound and infrared imaging of the heart arteries in patients with coronary artery disease undergoing coronary artery stenting. |
| Scientific title | The release of Phospholipase A2 biomarkers during percutaneous coronary intervention in patients with significant coronary artery disease and the relationship of released biomarkers with optical coherence tomography and intravascular ultrasound tissue characterisation. |
| Primary sponsor | Sir Charles Gairdner Hospital |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Coronary artery disease; Coronary artery disease;Cardiovascular - Coronary heart disease |
| Interventions | Invasive imaging of the coronary arteries prior to and after elective coronary stenting with optical coherence tomography and intravascular ultrasound. Imaging will take place on two occasions approximately 30 minutes apart and will take… |
| Registration date | Aug 16, 2011 |
| Target size | 50 |
| Secondary IDs | SCGH 2011-082 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: